Life Sciences Biz NanoString Gets OK For $393M Ch. 11 Sale

By Clara Geoghegan · April 19, 2024, 5:22 PM EDT

Insolvent biotech company NanoString can be sold to scientific instrument maker Bruker Corp., a Delaware bankruptcy judge ruled Friday, after the buyer clinched the winning bid during a 14-hour Chapter 11...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

NanoString Technologies, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

February 04, 2024

Recent Articles By Clara

October 03, 2024
Dental Laser Co. Can Tap $5M DIP For Swift Ch. 11 Sale Plans
July 09, 2024
Glocal Says UpHealth Coerced Acquisition In Ch. 11 Suit
June 24, 2024
LifeWallet Calls Cano Health's Ch. 11 Plan Unconfirmable
May 17, 2024
Steward Health Ch. 11 Lifts Lid On PE In Healthcare
March 25, 2024
Judge Probes If $54M Deal Will Affect Tehum Care Ch. 11 Plan
March 05, 2024
Rite Aid Process To Break Leases, Close Stores In Ch. 11 OK'd
February 14, 2024
Pharma Co. Humanigen Gets OK For Ch. 11 Sale
February 13, 2024
FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale
January 29, 2024
Shumaker Can't Get Double Fees For Appeal, Wilkes Says
January 25, 2024
Service Snag Delays Hospital Operator's Ch. 11 Confirmation